Deborah Lee Bevvino Psychologist Medicare: Medicare Enrolled Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
Michael Magdalinski Psychologist Medicare: Accepting Medicare Assignments Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
Dr. Ramona Roberts, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 517 Reading Ave, West Reading, PA 19611 Phone: 954-914-4138 |
George Woodruff Psychologist Medicare: Medicare Enrolled Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
John Heilenman Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
Margaret Siebert Psychologist Medicare: Medicare Enrolled Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
Kevin Riley Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
Janet Sebes Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8070 |
Judith Warchal, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6th Avenue & Spruce Street, West Reading, PA 19611 Phone: 610-988-8446 |
News Archive
Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too.
Cyclacel Pharmaceuticals, Inc. announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes refractory to hypomethylating agents, such as azacitidine and decitabine. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
The chances of developing the disease rose by 17 per cent, even years after men stopped taking the vitamin, claim researchers. This comes right after the study which found women taking multivitamins and other supplements have an increased risk of dying.
onditions causing arrhythmia are among the most common cardiac conditions. A study headed by Prof. Georg Schmidt of the Technical University of Munich has demonstrated for the first time that the nocturnal respiratory rate can help with an important prediction: It is an indicator of whether a defibrillator will help to extend the life of patients with arrhythmia.
› Verified 4 days ago